DSIJ Mindshare

Dr. Reddy launches Guaifenesin and Pseudoephedrine

DSIJ Intelligence 0 3378 Article rating: 5.0

Dr. Reddy's Laboratories has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended-Release Tablets in two strengths-Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg in the United States market, as approved by the US Food and Drug Administration (USFDA).


RSS
First64256426642764286430643264336434Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR